Please login to the form below

Not currently logged in
Email:
Password:

Judith Cranford joins Ruder Finn

PR agency, Ruder Finn has announced the appointment of Judith Cranford as MD of health, advocacy and alliance development for its London office

PR agency, Ruder Finn has announced the appointment of Judith Cranford as MD of health, advocacy and alliance development for its London office.

Cranford joins from global communications firm, MS&L Worldwide where, as MD of health and advocacy, she was involved in managing European and global programmes for pharmaceutical and medical device companies, as well as non-governmental organisations.

Her past roles have included CEO of the National Osteoporosis Foundation (NOF) in Washington, DC. In this advocacy role, Cranford helped raise awareness of osteoporosis as a significant public health concern as part of her responsibilities to lead efforts in increasing understanding of the prevention, diagnosis and treatment of the bone disease.

She also has previous experience with Ruder Finn as healthcare business group director.

"Judith's international background and extensive experience in advocacy, alliance management and corporate social responsibility is significant to much of our healthcare work at Ruder Finn, both for corporate and non-profit clients," said Nick Leonard, MD for Ruder Finn London. "The strategic insight and leadership experience she brings is vital to successfully addressing the interests of industry, patients and healthcare professionals, particularly around access."

Cranford's new role will involve advancing Ruder Finn's activities in areas of pharmaceuticals, life sciences, global advocacy and public affairs, as well as innovating new strategies in emerging client challenges such as market access and the implications of social media in healthcare.

"Ruder Finn has a strong heritage in all aspects of healthcare communications," said Cranford. "I look forward to working with colleagues as we continue to evolve the practice. We want to support our clients by providing the ongoing creativity, strategic and innovative counsel that helps them to effectively address the diverse challenges of a complex and constantly changing health landscape."

13th May 2010

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Syneos Health™

Syneos Health™ is the only fully integrated biopharmaceutical solutions organization. Our company, including a Contract Research Organization (CRO) and Contract...

Latest intelligence

Theresa Heggie
Alnylam’s big moment: bringing groundbreaking RNAi drugs to Europe
Theresa Heggie talks about the biotech’s 16-year path to market, and the promise of its ‘gene silencing’ medicines...
patients
Retaining reader value in plain language summaries of clinical studies
Balancing the risk of misinterpretation with the public’s ability to understand simplified plain-language summaries...
Can we talk about the ego-bias and chemicals influencing your target audience’s behaviour?
Over the Summer, the Page & Page team became fascinated by two books on this very subject. Two books from one author, Dean Burnett, an eminent neuroscientist, lecturing at Cardiff...

Infographics